Schirrmacher V - Search Results

1

Tumor stimulator cell modification by infection with Newcastle Disease Virus: analysis of effects and mechanism in MLTC-CML cultures.

Schirrmacher V, Jurianz K, Roth C, Griesbach A, Bonifer R, Zawatzky R. Schirrmacher V, et al. Int J Oncol. 1999 Feb;14(2):205-15. doi: 10.3892/ijo.14.2.205. Int J Oncol. 1999. PMID: 9917494

2

Interferon production in the murine mixed lymphocyte culture. I. Interferon production caused by differences in the H-2 K and H-2 D region but not by differences in the I region or the M locus.

Kirchner H, Zawatzky R, Schirrmacher V. Kirchner H, et al. Among authors: schirrmacher v. Eur J Immunol. 1979 Jan;9(1):97-9. doi: 10.1002/eji.1830090121. Eur J Immunol. 1979. PMID: 155529

3

Production of interferon in the murine mixed lymphocyte culture. II. Interferon production is a T cell-dependent function, independent of proliferation.

Kirchner H, Zawatzky R, Engler H, Schirrmacher V, Becker H, von Wussow P. Kirchner H, et al. Among authors: schirrmacher v. Eur J Immunol. 1979 Oct;9(10):824-6. doi: 10.1002/eji.1830091015. Eur J Immunol. 1979. PMID: 160324

4

Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trial.

Schlag P, Manasterski M, Gerneth T, Hohenberger P, Dueck M, Herfarth C, Liebrich W, Schirrmacher V. Schlag P, et al. Among authors: schirrmacher v. Cancer Immunol Immunother. 1992;35(5):325-30. doi: 10.1007/BF01741145. Cancer Immunol Immunother. 1992. PMID: 1394336 Free PMC article. Clinical Trial.

5

An analysis of autologous T-cell anti-tumour responses in colon-carcinoma patients following active specific immunization (ASI).

Patel BT, Lutz MB, Schlag P, Schirrmacher V. Patel BT, et al. Among authors: schirrmacher v. Int J Cancer. 1992 Jul 30;51(6):878-85. doi: 10.1002/ijc.2910510608. Int J Cancer. 1992. PMID: 1639535 Clinical Trial.

6

Specific eradication of micrometastases by transfer of tumour-immune T cells from major-histocompatibility-complex congenic mice.

Schirrmacher V, von Hoegen P, Griesbach A, Schild HJ, Zangemeister-Wittke U. Schirrmacher V, et al. Cancer Immunol Immunother. 1991;32(6):373-81. doi: 10.1007/BF01741332. Cancer Immunol Immunother. 1991. PMID: 1826094 Free PMC article.

7

In vitro and clinical characterisation of a Newcastle disease virus-modified autologous tumour cell vaccine for treatment of colorectal cancer patients.

Liebrich W, Schlag P, Manasterski M, Lehner B, Stöhr M, Möller P, Schirrmacher V. Liebrich W, et al. Among authors: schirrmacher v. Eur J Cancer. 1991;27(6):703-10. doi: 10.1016/0277-5379(91)90170-i. Eur J Cancer. 1991. PMID: 1829908

8

In situ activation of syngeneic tumour-specific cytotoxic T lymphocytes: intra-pinna immunization followed by restimulation in the peritoneal cavity.

Schirrmacher V, Leidig S, Griesbach A. Schirrmacher V, et al. Cancer Immunol Immunother. 1991;33(5):299-306. doi: 10.1007/BF01756594. Cancer Immunol Immunother. 1991. PMID: 1868488 Free PMC article.

9

Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells.

Notter M, Schirrmacher V. Notter M, et al. Among authors: schirrmacher v. Int J Cancer. 1990 May 15;45(5):834-41. doi: 10.1002/ijc.2910450508. Int J Cancer. 1990. PMID: 2159436

10

Isolation of a human melanoma adapted Newcastle disease virus mutant with highly selective replication patterns.

Ahlert T, Schirrmacher V. Ahlert T, et al. Among authors: schirrmacher v. Cancer Res. 1990 Sep 15;50(18):5962-8. Cancer Res. 1990. PMID: 2203523

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

402 results

Search Page

Filters